Resuscitating a Culture One Beat at a Time
Executive Summary
Its acquisition of privately held Zymed means more to the Healthcare Solutions Group (HSG) of Agilent Technologies than being able to fill a gap in its cardiology business. It is also a part of Agilent's drive to energize its corporate culture following its spin-out of Hewlett-Packard last year. Moreover, in the face of disappointing earnings from HSG and poor near-term growth prospects, Agilent's overall commitment to health care was questioned by Wall Street.
You may also be interested in...
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.
Generic Or Innovator? Sandoz Sues CMS Over Potential Change In Rebate Classification
Sandoz argued against paying higher rebates for two of its drugs via the Centers for Medicare and Medicaid Services’ Medicaid drug rebate program in a US court six years after the suggestion was first made.